 |
 |
A G E N D A
Rheumatology Quality Stakeholders’ Summit
September 20, 2007, 8:30 AM – 4:30 PM
Hamilton Crowne Plaza, Washington, D.C.
8:00-8:15 AM Introductory Remarks
- Welcome, Neal Birnbaum, MD
- Review Meeting Purpose and Agenda, Stan Cohen, MD
- Review of ACR Quality Activities, Dan Solomon, MD, MPH
8:15-8:45 AM ABIM’s Role in the Quality Movement, Christine Cassel, MD, President, ABIM
8:45 AM-12:15 PM Quality Indicators for Arthritis
- ACR Quality Indicators, Catherine MacLean, MD, WellPoint
- CMS Perspective, Thomas Valuck, MD, CMS
- Employer Perspective, Edison Machado Jr., MD, MBA, Bridges to Excellence
10:00-10:15 AM Break
- Insurance Company Perspectives
- Stanford Shoor, MD, Kaiser Permanente
- Catherine MacLean, MD, WellPoint, Inc
- Lewis Sandy, MD, UnitedHealth Group
- Thomas Lynn, MD, Ingenix/Symmetry Products
Panel Discussion
12:15-1:00 PM Lunch
1:00-3:00 PM The Future of Quality Measures: From Process to Outcomes and Efficiency
- Defining Efficiency Measurement, Ryan Mutter, PhD, AHRQ
- Defining Outcome Measurement, Larry Anderson, MD, MMC-PHO
- Quality Organizations’ Perspective, Helen Burstin MD, MPH, NQF
- Weighing the Pros and Cons of Process, Outcomes and Efficiency, Robert Brook, MD, ScD, RAND
Panel Discussion
3:00-3:15 PM Conclusions and Next Steps – Dan Solomon, MD, MPH
3:15-3:30 PM Break
3:30-4:30 PM ACR Quality Management Tool Outcome Sciences Staff
- Demonstration of ACR Quality Management Tool (QMT)
- Q&A re: tool
|
|
|
